INS and Hyperglycemia: Major adverse effects of calcineurin inhibitors include hyperglycemia or posttransplantation diabetes mellitus (PTDM), which has been attributed to pancreatic β-cell dysfunction and defective insulin release82, while other mechanisms such as insulin resistance might also contribute101.